Bicyclol Alleviates Atherosclerosis by Manipulating Gut Microbiota (Small 9/2022)
Xiaolin Li(Jinggangshan University), Lulu Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Shuwang He(Shandong University), Xiaolei Ma, Wensheng Zheng(Chinese Academy of Medical Sciences & Peking Union Medical College), Xiao‐You Yu(Chinese Academy of Medical Sciences & Peking Union Medical College), Jinlan Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Pei Lan(Chinese Academy of Medical Sciences & Peking Union Medical College), Yongsheng Che(Chinese Academy of Medical Sciences & Peking Union Medical College), Cong Li(Hangzhou Normal University), Rui Li(Iowa State University), Peng Du(Chinese Academy of Medical Sciences & Peking Union Medical College), Huihui Guo(Chinese Academy of Medical Sciences & Peking Union Medical College), Jin‐Jin Cui(Chinese Academy of Medical Sciences & Peking Union Medical College), Miao Lin(Chinese Academy of Medical Sciences & Peking Union Medical College), Jian‐Dong Jiang(Ningbo University)
Cited by 1
Related Papers
ON01910, a non-ATP-competitive small molecule inhibitor of Plk1, is a potent anticancer agent
|Cancer Cell|2005|368
Azvudine is a thymus-homing anti-SARS-CoV-2 drug effective in treating COVID-19 patients
|Signal Transduction and Targeted Therapy|2021|210
Chlorogenic acid effectively treats cancers through induction of cancer cell differentiation
|Theranostics|2019|185
Loss of Epigenetic Control of <i>Synuclein-γ</i> Gene as a Molecular Indicator of Metastasis in a Wide Range of Human Cancers
|Cancer Research|2005|179
Extracellular Signal-Regulated Kinase–Dependent Stabilization of Hepatic Low-Density Lipoprotein Receptor mRNA by Herbal Medicine Berberine
|Arteriosclerosis Thrombosis and Vascular Biology|2005|171